TSX closed
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Invest your way with confidence.

  • ✓Powerful tools & research — at no extra cost
  • ✓Stocks, ETFs, options & more
  • ✓Competitive fees + USD accounts
Stocks/NASDAQ/RPRX

Royalty Pharma Plc (RPRX : NASDAQ)

Common Stock

$57.78

USD

+0.85 (1.49%)

Last updated: 2026-10-12

Follow RPRX

RPRX

Royalty Pharma Plc

Source:WealthAwesomeWealthAwesome
↓ $3.63 (-5.91%)
30 day period
$56.21$60.09$63.96Aug 31Sep 22Oct 12

Performance

1 Day

+1.49%

1 Week

+1.98%

1 Month

-1.42%

YTD

+50.73%

Key Statistics

Market Cap

$32.90B

52W High

$64.38

52W Low

$35.11

P/E Ratio

30.28

50 Day MA

$59.16

200 Day MA

$51.53

Beta

0.41

Dividend Yield

1.62%

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/12/2026$57.04$57.92$56.85$57.78$57.782,163,051
10/9/2026$56.03$57.08$55.72$56.93$56.932,882,000
10/8/2026$56.57$56.71$55.13$56.21$56.212,540,314
10/7/2026$56.60$57.16$56.41$56.76$56.763,286,730
10/6/2026$56.66$57.13$56.04$56.44$56.442,434,244
10/5/2026$57.10$57.25$56.01$56.66$56.663,770,322
10/2/2026$57.63$57.91$56.96$57.16$57.162,229,500
10/1/2026$58.36$58.40$57.22$57.63$57.633,245,200
9/30/2026$58.07$58.64$57.70$58.36$58.363,653,700
9/29/2026$58.19$58.48$57.51$58.22$58.222,885,200

Analyst Price Targets

Based on 8 analysts covering RPRX · as of Oct 8, 2026

📈

Wall Street analysts forecast RPRX stock price to rise 13.1% over the next 12 months.

Consensus

Strong Buy

4.50 / 5.00

Avg. Target

US$65.38

+13.1% Upside

Previously US$65.13 on Oct 5, 2026

Current Price

US$57.78

Last close

Analyst Breakdown (8 analysts)

Strong Buy 5
Buy 2
Hold 1
Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on RPRX's historical volatility

HistoricalForecast68%95%
US$42.58US$49.60US$56.61US$63.63US$70.65US$77.66TodayJun 4Aug 10Oct 12Nov 24Jan 7Feb 19

30-Day Vol

22.6%

Annualized

90-Day Vol

24.4%

Annualized

Trend (90d)

-1.2%

Annualized drift

90d Mean

US$57.53

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$57.70US$53.36 – US$62.38
60 trading daysUS$57.61US$51.59 – US$64.34
90 trading daysUS$57.53US$50.25 – US$65.86

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Royalty Pharma Plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

Financials

Revenue (TTM)
$2.54B
EBITDA
$1.56B
Profit Margin
32.02%
ROE (TTM)
13.97%
EPS (Diluted)
1.88
Book Value
15.33

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About RPRX.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
MNDRMobile-health Network Solutions Class A Ordinary Shares$3.04+257.65%
LNKSLinkers Industries Limited Class A Ordinary Shares$2.27+138.37%
YMATJ-Star Holding Co., Ltd. Ordinary Shares$2.91+125.58%
CLWTEuro Tech Holdings Company Ltd$2.15+58.09%
BMBLBumble Inc$3.80+49.61%
SKYASkyAI, Inc.$2.60+42.86%
WFFWF Holding Limited Ordinary Shares$17.28+40.60%
NCPLNetcapital Inc$1.54+35.09%

RPRX.US news timeline

1 article covering RPRX.US, most recent first

Latest

Royalty Pharma (RPRX) Offers Attractive Risk-Reward Profiles at Reasonable Multiples

•Stocks

Advertisement